|
1
|
Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe
AS, et al; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force
for the Universal Definition of Myocardial Infarction; ESC
Committee for Practice Guidelines (CPG), . Third universal
definition of myocardial infarction. Eur Heart J. 33:2551–2567.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang CJ, Chen PC, Lin CS, Tsai CL and Tsai
SH: Thrombolytic therapy-associated acute myocardial infarction in
patients with acute ischemic stroke: A treatment dilemma. Am J
Emerg Med. 35:804.e1–804.e3. 2017. View Article : Google Scholar
|
|
3
|
Ariza-Sole A, Alegre O, Elola FJ,
Fernandez C, Formiga F, Martinez-Selles M, Bernal JL, Segura JV,
Iniguez A, Bertomeu V, et al: Management of myocardial infarction
in the elderly. Insights from Spanish Minimum Basic Data Set. Eur
Heart J Acute Cardiovasc Care. July 1–2017.(Epub ahead of print).
View Article : Google Scholar
|
|
4
|
Kuster GW, Baruzzi AC, Pacheco EP,
Domingues RB, Pieruccetti M, Giacon LM, Garcia JC, Furlan V and
Massaro AR: Early reperfusion therapy in acute ischemic stroke
after recent myocardial infarction. Arq Neuropsiquiatr. 74:690–691.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Widimsky P, Coram R and Abou-Chebl A:
Reperfusion therapy of acute ischaemic stroke and acute myocardial
infarction: Similarities and differences. Eur Heart J. 35:147–155.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zerna C, Hegedus J and Hill MD: Evolving
treatments for acute ischemic stroke. Circ Res. 118:1425–1442.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan J and Watanabe T: Inflammatory
reactions in the pathogenesis of atherosclerosis. J Atheroscler
Thromb. 10:63–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dewberry R, Holden H, Crossman D and
Francis S: Interleukin-1 receptor antagonist expression in human
endothelial cells and atherosclerosis. Arterioscler Thromb Vasc
Biol. 20:2394–2400. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akita K, Isoda K, Sato-Okabayashi Y,
Kadoguchi T, Kitamura K, Ohtomo F, Shimada K and Daida H: An
interleukin-6 receptor antibody suppresses atherosclerosis in
atherogenic mice. Front Cardiovasc Med. 4:842017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boutin H, LeFeuvre RA, Horai R, Asano M,
Iwakura Y and Rothwell NJ: Role of IL-1α and IL-1β in ischemic
brain damage. J Neurosci. 21:5528–5534. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sordillo PP, Sordillo LA and Helson L:
Bifunctional role of pro-inflammatory cytokines after traumatic
brain injury. Brain Inj. 30:1043–1053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Katakami N, Kaneto H, Osonoi T, Kawai K,
Ishibashi F, Imamura K, Maegawa H, Kashiwagi A, Watada H, Kawamori
R, et al: Transforming growth factor beta1 T868C gene polymorphism
is associated with cerebral infarction in Japanese patients with
type 2 diabetes. Diabetes Res Clin Pract. 94:e57–60. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan N, Wang J, Deng Y, Zhu J, Mei J, Chen
Y and Yang H: Association between genetic polymorphisms of
interleukins and cerebral infarction risk: a meta-analysis. Biosci
Rep. 36:e004042016.doi: 10.1042/BSR20160226. PubMed/NCBI
|
|
14
|
Mariotti M, Castiglioni S, Bernardini D
and Maier JA: Interleukin 1 alpha is a marker of endothelial
cellular senescent. Immun Ageing. 3:42006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Slowik A, Borratynska A, Turaj W, Pera J,
Dziedzic T, Wloch D, Szczudlik A, Betlej M, Krzyszkowski T and
Czepko R: Interleukin 1beta-511 C/T polymorphism and risk of
aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry.
77:279–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Um JY, Moon KS, Lee KM, Yun JM, Cho KH,
Moon BS and Kim HM: Association of interleukin-1 alpha gene
polymorphism with cerebral infarction. Brain Res Mol Brain Res.
115:50–54. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li N, He Z, Xu J, Liu F, Deng S and Zhang
H: Association of PDE4D and IL-1 gene polymorphism with ischemic
stroke in a Han Chinese population. Brain Res Bull. 81:38–42. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ulvenstam A, Kajermo U, Modica A, Jernberg
T, Söderström L and Mooe T: Incidence, trends, and predictors of
ischemic stroke 1 year after an acute myocardial infarction.
Stroke. 45:3263–3268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hosomi N, Yoshimoto T, Kanaya Y, Neshige
S, Hara N, Himeno T, Kono R, Takeshima S, Takamatsu K, Ota T, et
al: Brain natriuretic peptide and particular left ventricle segment
asynergy associated with cardioembolic stroke from old myocardial
infarction. J Stroke Cerebrovasc Dis. 25:1165–1171. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lust JA, Lacy MQ, Zeldenrust SR,
Dispenzieri A, Gertz MA, Witzig TE, Kumar S, Hayman SR, Russell SJ,
Buadi FK, et al: Induction of a chronic disease state in patients
with smoldering or indolent multiple myeloma by targeting
interleukin 1{beta}-induced interleukin 6 production and the
myeloma proliferative component. Mayo Clin Proc. 84:114–122. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dominici R, Cattaneo M, Malferrari G,
Archi D, Mariani C, Grimaldi LM and Biunno I: Cloning and
functional analysis of the allelic polymorphism in the
transcription regulatory region of interleukin-1 alpha.
Immunogenetics. 54:82–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vohnout B, Di Castelnuovo A, Trotta R,
D'Orazi A, Panniteri G, Montali A, Donati MB, Arca M and Iacoviello
L: Interleukin-1 gene cluster polymorphisms and risk of coronary
artery disease. Haematologica. 88:54–60. 2003.PubMed/NCBI
|
|
23
|
Shiotani A, Sakakibara T, Nomura M,
Yamanaka Y, Nishi R, Imamura H, Tarumi K, Kamada T, Hata J and
Haruma K: Aspirin-induced peptic ulcer and genetic polymorphisms. J
Gastroenterol Hepatol. 25 Suppl 1:S31–S34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dziedzic T, Slowik A, Pera J and Szczudlik
A: Lack of association between interleukin-1 β polymorphism (−511)
and ischaemic stroke. J Neurol Neurosurg Psychiatry. 75:170–171.
2004.PubMed/NCBI
|
